Skip to main content
Log in

Efficacy of various dithiol compounds in acute As2O3 poisoning in mice

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The efficacy ofdl-dimercaptopropanol (British Anti-Lewisite, BAL),dl-dimercaptopropanesulfonate (DMPS), and meso-dimercaptosuccinic acid (DMS A) was compared in reducing the acute As2O3 toxicity in mice. Mice were treated with a single equimolar dose of a dithiol compound (0.7 mmol/kg i.p.) 0.5 or 30 min after the s.c. injection of various doses of As2O3. Both DMPS and DMSA were significantly (p<0.05) more effective in mice treated 0.5 min after the poisoning if compared to BAL on an equimolar level. The highest potency ratio (PR) (LD50 with treatment/LD5o without treatment) was found in animals injected with DMSA (PR=8.6). The corresponding value for DMPS was 4.2, and for BAL 2.1, respectively. In animals treated 30 min after poisoning the efficacy of DMPS (PR = 2.6) was similar to the efficacy of DMSA 2.4, both being only slightly superior to BAL 2.O. DMPS and DMSA were found to be much less toxic than BAL. The LD50 of arsenic was 0.057 mmol/kg. The efficacy of BAL, DMPS, and DMSA in reducing the tissue content of arsenic following acute As2O3 poisoning was investigated in mice (n=6/group) and guinea pigs (n=3-4/group). The animals were injected s.c. with 0.043 mmol/kg As2O3 (containing a tracer dose of74As(III)). Thirty minutes later the antidotes were administered A were more effective in reducing the arsenic content of tissues than BAL. Moreover, BAL caused accumulation of the toxicant in the brain. It is concluded that the recommendation of BAL as drug of choice in acute arsenic poisoning needs to be carefully re-evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aaseth J (1983) Recent advance in the therapy of metal poisonings with chelating agents. Hum Toxicol 2: 257–272

    PubMed  Google Scholar 

  • Aposhian HV (1982) Biological chelation: 2,3-dimercaptopropanesulfonic acid and meso-dimercaptosuccinic acid. Adv Enzyme Regul 20: 301–319

    Article  PubMed  Google Scholar 

  • Aposhian HV, Tadlock CH, Moon TE (1981) Protection of mice against the lethal effects of sodium arsenite — a quantitive comparison of a number of chelating agents. Toxicol Appl Pharmacol 61: 385–392

    Article  PubMed  Google Scholar 

  • Aposhian HV, Carter DE, Hoover TD, Hsu CA, Maiorino RM, Stine E (1984) DMSA, DMPS, and DMPA — as arsenic antidotes. Fundam Appl Toxicol 4: 58–70

    Article  PubMed  Google Scholar 

  • Cikrt M, Bencko V, Tichy M, Benes B (1980) Biliary excretion of74As and its distribution in the golden hamster after administration of74s(III) and74As (V). J Hyg Epidemiol Microbiol Immunol 24: 384–388

    PubMed  Google Scholar 

  • Eagle H, Magnuson HJ (1946) The systemic treatment of 227 cases of arsenic poisoning (encephalitis, dermatitis, blood dyscrasias, jaundice, fever) with 2,3-dimercaptopropanol (BAL). American Journal of Syphilis, Gonorrhoea, and Venereal Disease 30: 420–441

    Google Scholar 

  • Graziano JH, Cuccia D, Friedheim E (1978) The pharmacology of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning. J Pharmacol Exp Ther 207: 1051–1055

    PubMed  Google Scholar 

  • Hruby K, Donner A (1987) 2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning. Med Toxicol 2: 317–323

    Google Scholar 

  • Klaassen CD (1974) Biliary excretion of arsenic in rats, rabbits, and dogs. Toxicol Appl Pharmacol 29: 447–457

    Article  PubMed  Google Scholar 

  • Klaassen CD (1985) Heavy metals and heavy-metal antagonists. In: Gilman AG, Rall TW, Murad F (ed) Goodman and Gilman's The pharmacological basis of therapeutics. Macmillan Publ Co, New York, Toronto, London, pp 1605–1627

    Google Scholar 

  • Kreppel H, Szinicz L (1986) Reduction in toxicity of arsenic by 2,3-dimercapto-1-propanol (BAL), 2,3-dimercaptopropane-1-sulfonate sodium (DMPS), and 2,3-dimercaptosuccinic acid (DMSA) in mice. Naunyn Schmiedeberg's Arch Pharmacol 332 [suppl]: R 27

    Google Scholar 

  • Kreppel H, Reichl FX, Forth W (1987) Quantitative Bestimmung verschiedener Arsenverbindungen mittels Hydrid-AAS nach Auftrennung durch HPLC. In: Welz B (ed) 4. Colloquium Atomspektrometrische Spurenanalytik. Verlag Bodenseewerk Perkin-Elmer, Überlingen, pp 587–593

    Google Scholar 

  • Lenz K, Hruby K, Druml W, Eder A, Gaszner A, Kleinberger G, Pichler M, Weiser M (1981) 2,3-Dimercaptosuccinic acid in human arsenic poisoning. Arch Toxicol 47: 241–243

    Article  PubMed  Google Scholar 

  • Levander OA, Baumann CA (1966) Selenium metabolism. VI. Effect of arsenic on the excretion of selenium in the bile. Toxicol Appl Pharmacol 9: 106–115

    Article  PubMed  Google Scholar 

  • Liang YI, Chu CC, Tsen YL, Ting KS (1957) Studies on antibilharzial drugs. VI. The antidotal effects of sodium dimercaptosuccinate and BAL-glucoside against tartar emetic. Acta Physiol Sin 21: 24–32

    Google Scholar 

  • Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–113

    Google Scholar 

  • Maehashi H, Yamaguchi Y, Tsutsumi S (1983) Arsenic and copper excretion after treatment of arsenic poisoning in rats with heavymetal antagonists. Toxicol Lett 18 [suppl]: 116

    Article  Google Scholar 

  • National Research Council (1977) Arsenic. Medical and biological effects of environmental pollutants. Natl Acad Sci, Washington DC

    Google Scholar 

  • Okumura K, Lee IP, Dixon RL (1975) Permeability of selected drugs and chemicals across blood-testis barrier of the rat. J Pharmacol Exp Ther 194: 89–95

    PubMed  Google Scholar 

  • Peters RA, Stocken LA, Thompson RHS (1945) British Anti-Lewisite (BAL). Nature 156: 616–619

    Google Scholar 

  • Petrunkin VE (1956) Synthesis and properties of dimercapto derivates of alkylsulfonic acids. Ukr Khem Zh 22: 603–607

    Google Scholar 

  • Planas-Bohne F (1981) The influence of chelating agents on the distribution and biotransformation of methylmercuric chloride in rats. J Pharmacol Exp Ther 217: 500–504

    PubMed  Google Scholar 

  • Sachs L (1978) Angewandte Statistik; statistische Methoden und ihre Anwendung. Springer-Verlag, Berlin, Heidelberg, New York

    Google Scholar 

  • Szinicz L, Forth W (1988) Effect of arsenic on gluconeogenesis. Arch Toxicol 61: 444–449

    Article  PubMed  Google Scholar 

  • Tadlock CH, Aposhian HV (1980) Protection of mice against the lethal effects of sodium arsenite by 2,3-dimercapto-1-propane sulfonic acid and 2,3-dimercaptosuccinic acid. Biochem Biophys Res Commun 94: 501–507

    Article  PubMed  Google Scholar 

  • Tsutsumi S, Kawaguchi M, Ishii Y, Matsumoto Y (1983) Effects of dimercaprol or thioctic acid on the distribution and excretion of Na3 74AsO3 injected subcutaneously in rats. J Toxicol Sci 8: 197–203

    PubMed  Google Scholar 

  • Wildenauer DB, Reuther H, Weger N (1982) Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. I. Evidence for carrier mediated transport. Chem Biol Interact 42: 165–177

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kreppel, H., Reichl, F.X., Szinicz, L. et al. Efficacy of various dithiol compounds in acute As2O3 poisoning in mice. Arch Toxicol 64, 387–392 (1990). https://doi.org/10.1007/BF01973461

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01973461

Key words

Navigation